US private equity major GTCR’s Antylia Scientific portfolio company has agreed to sell its Masterflex business unit to Avantor for $2.9bn in an all-cash transaction.
The post GTCR to sell Antylia Scientific’s Masterflex unit in $2.9bn deal, two years after buyout first appeared on AltAssets Private Equity News.
